The International Partnership for Microbicides (IPM) is a product development partnership committed to developing safe and effective microbicides and other HIV prevention methods for use by women in developing countries. IPM’s engagement with major pharmaceutical partners in the HIV prevention effort has led to six non-exclusive royalty-free licensing agreements for IPM to develop, manufacture and distribute eight antiretroviral (ARV) compounds as microbicides in developing countries. These licenses ensure that any new products will be provided at little or no cost and made widely available where they are most urgently needed.
IPM has made no financial contribution for these licensing agreements, which serve as a model of public-private partnerships in fostering global health solutions. As part of the microbicide drug development process, IPM pays for the cost associated with product development and works in partnership with entities both the private and public sectors to carry out these efforts. IPM also makes its experience available to other product developers, seeking to improve global health by negotiating similar agreements with the private sector,
|Location||Southern Africa, Eastern Africa, Tanzania, Rwanda, South Africa|